Presentation of proposition and invocation response time

June 3, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that it has been presented with the outlines of the proposition of Salveo Holding S.A (‘Salveo’), the company’s major shareholder, underlying its request to convene an extraordinary general meeting of shareholders (‘EGM’) that shall be proposed to resolve on the appointment of a new CEO and the replacement of one non-executive director.

read more

Ms. Evi Mattil, CCO, will to take over the CEO functions ad interim

May 31, 2013 Group News
Tags
,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that following on Mr. Arnoud van Tulder’s retirement as Chief Executive Officer, effective June 1, 2013, Ms. Evi Mattil, Chief Commercial Officer, will to take over with immediate effect and on an ad interim basis the functions of Arnoud van Tulder. The search and formal procedure for the nomination of a new CEO will be started immediately.

Resignation Mr. Arnoud van Tulder as CEO

May 30, 2013 Group News
Tags

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr. Arnoud van Tulder will for personal reasons retire as Chief Executive Officer, effective June 1, 2013.

read more

Update of Matters Salveo

May 30, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces further to its press release dated 15 May and as a matter of update of matters regarding Salveo Holding S.A. (‘Salveo’), Cryo-Save’s new 27 % shareholder, that it has received a request by Salveo to convene an extraordinary general meeting of shareholders.

read more

Board change

May 23, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Company’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that the Board of Directors has decided to appoint its Non-Executive Director Mr. Walter van Pottelberge as Chairman of the Board as of today. Mr. Van Pottelberge will replace Mr. Johan Goossens, who will remain a NonExecutive Director.

AGM resolutions

May 15, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that all proposed resolutions at today’s AGM were passed, except for the proposal to cancel the shares currently held in treasury.

read more

Director shareholding – Block-trades

May 10, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, has been informed that via a block-trade Mr Johan Goossens, Chairman, sold 900,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) to Salveo Holding SA on 7 May 2013 and that at the same day Mr Marc Waeterschoot, co-founder and former Board Member of Cryo-Save, via a block-trade sold 1,460,000 Ordinary Shares to Salveo Holding SA, both at a price of €1.70. Salveo Holding SA has not contacted management of Cryo-Save about its intentions as a major shareholder.

read more

Cryo-Save facilitates the first transplantation in Spain to treat blackfan-diamond anaemia thanks to the cost-free donation program

April 29, 2013 Group News

A 4-year-old boy was treated for Blackfan-Diamond anaemia (BDA) with a stem cell transplant from his sister’s umbilical cord blood. The transplant was performed on April 25 at the Hospital del Niño Jesús in Madrid, one of the most important paediatric hospitals in Spain. It is the first transplant performed in this country to treat BDA with a cryo-preserved sample from a family bank, in this case, the leading Family Stem Cell Bank in Spain, Crio-Cord, a subsidiary of the Cryo-Save Group. This treatment was provided thanks to the Cryo-Save Cost Free Donation Program, which provides free storage of the umbilical cord blood and cord tissue stem cells for families who have a family member diagnosed with a disease treatable with stem cells.

read more